Camille Terfve

Camille is a unique computational biology and AI life science specialist, with unparalleled technical and patent experience in this specific field.

Camille has deep expertise in bioinformatics/computational biology, digital health, AI in the life sciences, and advanced bioprocessing. She has a passion for solutions that use data and tech to understand and leverage living systems to ultimately improve patient outcomes.

She regularly speaks at conferences and panel events which provides the ideal opportunity to bring her complex specialist subjects to life and to a wider audience.

Areas of Expertise

• Machine learning and AI
• Software based companion diagnostics
• In silico drug discovery & repurposing, protein engineering
• Advanced bioprocessing, control/monitoring and optimisation of bioprocesses
• Omics and high throughput assay technologies
• Digital pathology & medical image analysis
• Digital health

Clients

Camille’s clients include UK- and EU-based large and small biotechnology companies, universities and research charities. She also represents overseas clients at the European Patent Office, including multinational pharmaceutical companies, US biotech companies of all sizes, and US universities. 

She is experienced in providing advice on IP management, oppositions, freedom to operate, patentability, drafting and IP strategy, and has particular experience working with projects that have a large digital / data driven / in silico components. 

Background

Camille has a PhD from the University of Cambridge and the EMBL-European Bioinformatics Institute. Her PhD research focused on unsupervised learning approaches and the use of knowledge networks to reconstruct signalling networks in diseased cells.  Prior to that, she completed a Master’s degree in Bioengineering at the University of Brussels and a Masters in Computational Biology at the University of Cambridge. 

She joined Mewburn Ellis LLP in 2019, having qualified as a Chartered Patent Attorney and European Patent Attorney in 2018. She joined the partnership in 2022.